Brief: aTyr Pharma Inc Believes Cash Runway Will Extend Into 2026
March 9 (Reuters) - aTyr Pharma Inc LIFE.O :
* ATYR PHARMA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022
RESULTS
AND PROVIDES CORPORATE UPDATE
* ATYR PHARMA INC - BASED ON COMPANY'S CURRENT OPERATIONAL
PLANS
AND EXISTING CASH, ATYR BELIEVES COMPANY'S CASH RUNWAY WILL
EXTEND INTO 2026
* ATYR PHARMA INC - QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED
$0.26
Source text for Eikon: ID:nGNX3lX9fl
Further company coverage: LIFE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan